Chairperson’s Closing Comments and Vision Statement - The Evolving Therapeutic Roadmap for Atopic Dermatitis: The Foundation Role of Targeting Cytokine Signaling Systems in Patients with Moderate-to- Severe AD: Evidence for a Paradigm Shift for Optimizing Treatment Outcomes in Patients with AP - Thomas Bieber, MD, PhD, MDRA – Program Chair